Global Biotechnology/Pharmaceutical Services Outsourcing Market Size, Status and Forecast 2019-2025

SKU ID : QYR- 13679761

Publishing Date : 10-Jul-2019

No. of pages : 90

PRICE
3900
7800


  • When it comes to pharmaceutical research and development however, success is never guaranteed. The average cost of drug development can reach into the billions of dollars, and it takes an average of 10 years to bring a new drug to market. In addition, many drugs fail to be clinical effective and subsequently never see the light of day.
    Due to these risks, pharmaceutical companies are not always eager to utilize their onsite resources for drug R&D. Certain cost-saving measures implemented in the pharmaceutical space have included outsourcing these activities, helping organizations reduce both their operational and manufacturing costs, thereby lowering financial risk.
    North America held more than 50.0% share for the pharmaceutical/biotechnology services outsourcing market in 2015. The presence of several multinational and local consulting firms in this region contributed towards the growth in this region.
    Asia Pacific is anticipated to witness lucrative growth over the forecast period. Low cost of manufacturing and availability of qualified labor is likely to foster contract manufacturing in this region. Moreover, economic policy reforms in countries such as India and China are anticipated to create open and balanced economy, which presents ample opportunity for market players to invest in this region.
    In 2018, the global Biotechnology/Pharmaceutical Services Outsourcing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

    This report focuses on the global Biotechnology/Pharmaceutical Services Outsourcing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biotechnology/Pharmaceutical Services Outsourcing development in United States, Europe and China.

    The key players covered in this study
    Quantic Group
    QuintilesIMS
    Parexel International Corporation
    Lachman Associates
    GMP Pharmaceuticals
    Management Forum
    Quality Context
    Inspired Pharma
    Concept Heidelberg GmbH
    RSSL

    Market segment by Type, the product can be split into
    Consulting
    Auditing & Assessment
    Regulatory Affairs
    Product Maintenance
    Product Design & Development
    Product Testing & Validation
    Training & Education
    Others

    Market segment by Application, split into
    Regenerative Medicine
    Biobanking
    Drug Discovery

    Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Biotechnology/Pharmaceutical Services Outsourcing status, future forecast, growth opportunity, key market and key players.
    To present the Biotechnology/Pharmaceutical Services Outsourcing development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

    In this study, the years considered to estimate the market size of Biotechnology/Pharmaceutical Services Outsourcing are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.